Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02373332 · ClinicalTrials.gov registry record
Fatty Acid Regulation of Platelet Function in Diabetes
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 90
- Enrollment target
NCT02373332 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 90 participants.
The verdict
NCT02373332 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study investigates the potential protective effects of altering fatty acid in the platelet as a method for prevention of platelet activation and thrombosis in type 2 diabetes mellitus. Fatty acids (omega-3 and omega-6) and their oxidized lipids will be evaluated for protection from agonist-mediated platelet activation in platelets from type 2 diabetics and healthy controls.
Interventions
- OTHER omega-3 and -6 fatty acids and their 12-LOX oxylipins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-05-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02373332
The ClinicalTrials.gov registry entry for NCT02373332 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which omega-3 and -6 fatty acids and their 12-LOX oxylipins is the first listed.
NCT02373332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02373332 about?
NCT02373332 is a clinical study titled "Fatty Acid Regulation of Platelet Function in Diabetes". This study investigates the potential protective effects of altering fatty acid in the platelet as a method for prevention of platelet activation and thrombosis in type 2 diabetes mellitus. Fatty acids (omega-3 and omega-6) and their oxidized lipids will be evaluated for protection from agonist-medi...
What is the current status of trial NCT02373332?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2013-08. Estimated completion is 2019-05-21.
What interventions are being tested in trial NCT02373332?
The interventions under investigation include: omega-3 and -6 fatty acids and their 12-LOX oxylipins (OTHER).
Who is sponsoring clinical trial NCT02373332?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.